Epanova...Do not see it happening...As advertised is 850 mg/1gm capsules of n-3s...Not clear on what the remaining 15% is...
No reason to believe the EPA/DHA ratio in this mixture is not one to one..So four caps (the daily recommended dose) should give you 1.6 gms of EPA...vs 4gm dose of EPA in V.
You can throw out the DHA unless you are planning on giving this to newborns..DHA has little or no proven value in reducing CVD risk or Systemic Inflammation..and in fact is the main reason for GI issues like gastric distress and diarrhea (15% in patients taking 4 gms of Epanova)..
There is much ballyhoo about clinicians not understanding how V works (hint..it is not a statin)...But don't think for a minute there is not a library of scientific information on how EPA works..A lot of it related to the EPA/AA ratios...Something that will come out hopefully in the near future...on how the EPA/AA ratios line up with CVD event risk in R-I..
Epanova is just watered down V with an unpleasant and virtually useless additive (the DHA)....E will reduce CVD risk only to the extent it increases the EPA/AA ratio...Which should roughly be 30% of Vs effect at suggested dosages...
Most of us could live without the diarrhea and the upset stomach.
Have they missed the fact Epanova doesn’t have cardiovascular IP? Yes. Have they missed the fact Amarin has crossover Epanova IP? Yes. Is this FUD? Yes. BB
News 
Market Data 
Discover 
